BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24550143)

  • 1. Curcumin suppresses proliferation of colon cancer cells by targeting CDK2.
    Lim TG; Lee SY; Huang Z; Lim DY; Chen H; Jung SK; Bode AM; Lee KW; Dong Z
    Cancer Prev Res (Phila); 2014 Apr; 7(4):466-74. PubMed ID: 24550143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Natural Degradant of Curcumin, Feruloylacetone Inhibits Cell Proliferation via Inducing Cell Cycle Arrest and a Mitochondrial Apoptotic Pathway in HCT116 Colon Cancer Cells.
    Chou YT; Koh YC; Nagabhushanam K; Ho CT; Pan MH
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation.
    Akiyama T; Sugiyama K; Shimizu M; Tamaoki T; Akinaga S
    Jpn J Cancer Res; 1999 Dec; 90(12):1364-72. PubMed ID: 10665655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells.
    Moragoda L; Jaszewski R; Majumdar AP
    Anticancer Res; 2001; 21(2A):873-8. PubMed ID: 11396178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor.
    Whittaker SR; Barlow C; Martin MP; Mancusi C; Wagner S; Self A; Barrie E; Te Poele R; Sharp S; Brown N; Wilson S; Jackson W; Fischer PM; Clarke PA; Walton MI; McDonald E; Blagg J; Noble M; Garrett MD; Workman P
    Mol Oncol; 2018 Mar; 12(3):287-304. PubMed ID: 29063678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.
    Chen A; Xu J
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G447-56. PubMed ID: 15486348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.
    Ni HJ; Chang YN; Kao PH; Chai SP; Hsieh YH; Wang DH; Fong JC
    Biochim Biophys Acta; 2012 Dec; 1820(12):1893-900. PubMed ID: 22906975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression.
    Zakraoui O; Marcinkiewicz C; Aloui Z; Othman H; Grépin R; Haoues M; Essafi M; Srairi-Abid N; Gasmi A; Karoui H; Pagès G; Essafi-Benkhadir K
    Mol Carcinog; 2017 Jan; 56(1):18-35. PubMed ID: 26824338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of telomerase activity by diclofenac and curcumin is associated with cell cycle arrest and induction of apoptosis in colon cancer.
    Rana C; Piplani H; Vaish V; Nehru B; Sanyal SN
    Tumour Biol; 2015 Aug; 36(8):5999-6010. PubMed ID: 25744732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of N-alkyl or aryl substituted isoindigo derivatives as potential dual cyclin-dependent kinase 2 (CDK2)/glycogen synthase kinase 3β (GSK-3β) phosphorylation inhibitors.
    Zhao P; Li Y; Gao G; Wang S; Yan Y; Zhan X; Liu Z; Mao Z; Chen S; Wang L
    Eur J Med Chem; 2014 Oct; 86():165-74. PubMed ID: 25151579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K/AKT/mTOR and PKC-theta signaling pathways in human breast carcinoma cells.
    Badr G; Gul HI; Yamali C; Mohamed AAM; Badr BM; Gul M; Abo Markeb A; Abo El-Maali N
    Bioorg Chem; 2018 Aug; 78():46-57. PubMed ID: 29533214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo.
    Zhou QM; Wang XF; Liu XJ; Zhang H; Lu YY; Su SB
    Acta Pharmacol Sin; 2011 Nov; 32(11):1402-10. PubMed ID: 21986579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases.
    Ukomadu C; Dutta A
    J Biol Chem; 2003 Oct; 278(44):43586-94. PubMed ID: 12930830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.
    Kang J; Sergio CM; Sutherland RL; Musgrove EA
    BMC Cancer; 2014 Jan; 14():32. PubMed ID: 24444383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells.
    Lee YK; Park SY; Kim YM; Park OJ
    Ann N Y Acad Sci; 2009 Aug; 1171():489-94. PubMed ID: 19723094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6,7,4'-trihydroxyisoflavone inhibits HCT-116 human colon cancer cell proliferation by targeting CDK1 and CDK2.
    Lee DE; Lee KW; Jung SK; Lee EJ; Hwang JA; Lim TG; Kim BY; Bode AM; Lee HJ; Dong Z
    Carcinogenesis; 2011 Apr; 32(4):629-35. PubMed ID: 21258042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative and apoptosis-inducing activity of curcumin against human gallbladder adenocarcinoma cells.
    Ono M; Higuchi T; Takeshima M; Chen C; Nakano S
    Anticancer Res; 2013 May; 33(5):1861-6. PubMed ID: 23645731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle regulation and apoptotic cell death in experimental colon carcinogenesis: intervening with cyclooxygenase-2 inhibitors.
    Saini MK; Sanyal SN
    Nutr Cancer; 2015; 67(4):620-36. PubMed ID: 25825916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin synergizes the growth inhibitory properties of Indian toad (Bufo melanostictus Schneider) skin-derived factor (BM-ANF1) in HCT-116 colon cancer cells.
    Giri B; Gomes A; Sengupta R; Banerjee S; Nautiyal J; Sarkar FH; Majumdar AP
    Anticancer Res; 2009 Jan; 29(1):395-401. PubMed ID: 19331178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.
    Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R
    Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.